APA (7th ed.) Citation

Gasthuys, E., Houben, R., Haesendonck, R., De Baere, S., Sys, S. U., Morrens, J., & Antonissen, G. (2019). Development of an in Vivo Lipopolysaccharide Inflammation Model to Study the Pharmacodynamics of COX-2 Inhibitors Celecoxib, Mavacoxib, and Meloxicam in Cockatiels (Nymphicus hollandicus). Journal of avian medicine and surgery, 33(4), 349-360. https://doi.org/10.1647/2018-391

Chicago Style (17th ed.) Citation

Gasthuys, Elke, Renée Houben, Roel Haesendonck, Siegrid De Baere, Stanislas U. Sys, Joachim Morrens, and Gunther Antonissen. "Development of an in Vivo Lipopolysaccharide Inflammation Model to Study the Pharmacodynamics of COX-2 Inhibitors Celecoxib, Mavacoxib, and Meloxicam in Cockatiels (Nymphicus Hollandicus)." Journal of Avian Medicine and Surgery 33, no. 4 (2019): 349-360. https://doi.org/10.1647/2018-391.

MLA (9th ed.) Citation

Gasthuys, Elke, et al. "Development of an in Vivo Lipopolysaccharide Inflammation Model to Study the Pharmacodynamics of COX-2 Inhibitors Celecoxib, Mavacoxib, and Meloxicam in Cockatiels (Nymphicus Hollandicus)." Journal of Avian Medicine and Surgery, vol. 33, no. 4, 2019, pp. 349-360, https://doi.org/10.1647/2018-391.